Key result
Mass spectrometry-assisted structure-activity relationship studies identified benzimidazole derivatives with sub-micromolar binding affinity for the HCV RNA IRES IIA subdomain.
Answers are grounded in this paper and cite their sources.
Mass spectrometry-based screening identified benzimidazole derivatives with sub-micromolar binding affinity for the HCV RNA IRES IIA subdomain, demonstrating activity in cellular assays.
A new class of small molecules that bind the HCV RNA IRES IIA subdomain with sub-micromolar affinity is reported. The benzimidazole 'hit' 1 with a KD approximately 100 microM to a 29-mer RNA model of Domain IIA was identified from a 180000-member library using mass spectrometry-based screening methods. Further MS-assisted SAR (structure-activity relationships) studies afforded benzimidazole derivatives with sub-micromolar binding affinity for the IIA RNA construct. The optimized benzimidazoles demonstrated activity in a cellular replicon assay at concentrations comparable to their KD for the RNA target.
No takes yet. Share an insight, caveat, or question.
Seth et al. (2005) studied Hepatitis C Virus. Benzimidazole derivatives was evaluated on Binding affinity to HCV RNA IRES IIA subdomain and cellular replicon assay activity. Mass spectrometry-assisted structure-activity relationship studies identified benzimidazole derivatives with sub-micromolar binding affinity for the HCV RNA IRES IIA subdomain.
Synapse has enriched 10 related papers. Consider them for comparative context: